Endonovo Therapeutics Inc (ENDV)

[Seaheck]

Unfortunately in startup biotech companies, dilution is a necessary evil. So it's going to happen no matter what. But if we can replace 2.1M shares of it, I'm happy. That's almost 1% of the o/s. So whenever you end up selling your shares, there will be an extra 1% of profits that you can thank this sole buyback for. I'm not complaining about an extra 1% of profits, that's for sure.